| 185 | 0 | 216 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探究长链非编码RNA(lncRNA)LUCAT1对人胰腺癌细胞MIA PaCa-2生物学行为的影响，探讨LUCAT1在胰腺癌恶性进展中的潜在作用。方法 在线数据库GEPIA分析LUCAT1在胰腺癌中的突变及表达情况；q-PCR实验检测对比人胰腺导管细胞HPNE及人胰腺癌细胞中LUCAT1的表达水平；FISH检测人胰腺癌组织中LUCAT1表达及分布。CCK-8实验和Transwell实验检测LUCAT1对MIA PaCa-2细胞增殖、凋亡、耐药及迁移能力的影响。基因集合富集分析比对LUCAT1参与的相关信号通路，Western blot实验验证蛋白质表达水平。结果 GEPIA分析结果显示，LUCAT1在人胰腺癌组织中表达水平上调；q-PCR实验结果显示，人胰腺癌细胞中LUCAT1高表达，差异有统计学意义(P<0.05)。敲低及过表达LUCAT1可影响胰腺癌细胞增殖、凋亡、吉西他滨耐药性以及迁移和侵袭能力(P<0.05)。在胰腺癌中LUCAT1影响p-Akt表达水平，并在Akt抑制剂MK-2206处理后相关功能被抑制。结论 LUCAT1通过PI3K-Akt信号通路调控胰腺癌细胞MIA PaCa-2恶性进展。
Abstract：Objective To investigate the effect of long non-coding RNA LUCAT1(lncRNA LUCAT1) on the biological behavior of MIA PaCa-2 in human pancreatic cancer cells, and to explore the potential role of LUCAT1 in the malignant progression of pancreatic cancer. Methods The mutation and expression of LUCAT1 in pancreatic cancer were analyzed by GEPIA, the expression levels of LUCAT1 in human pancreatic ductal cells HPNE and human pancreatic cancer cells were detected by q-PCR, and the expression and distribution of LUCAT1 in human pancreatic cancer tissues were detected by FISH. CCK-8 assay and Transwell assay were used to detect the effects of LUCAT1 on the proliferation, apoptosis, drug resistance, and migration of MIA PaCa-2 cells. Gene ensemble enrichment analysis was performed to compare the related signaling pathways involved in LUCAT1, and Western blot assay was used to verify the protein expression level. Results The results of GEPIA analysis showed that the expression level of LUCAT1 in human pancreatic cancer tissues was up-regulated, and the expression of LUCAT1 in human pancreatic cancer cells was significantly higher(P<0.05). Knockdown and overexpression of LUCAT1 could affect the proliferation, apoptosis, gemcitabine resistance, migration and invasion of pancreatic cancer cells, and the differences were statistically significant(P<0.05). In addition, LUCAT1 affected p-Akt expression levels in pancreatic cancer and was inhibited after treatment with Akt inhibitor MK-2206. Conclusion LUCAT1 regulates the malignant progression of MIA PaCa-2 in pancreatic cancer cells through the PI3K-Akt signaling pathway.
[1] Giaquinto A N,Miller K D,Tossas K Y,et al.Cancer statistics for African American/black people 2022[J].CA Cancer J Clin,2022,72(3):202-29.doi:10.3322/caac.21718.
[2] Rahib L,Smith B D,Aizenberg R,et al.Projecting cancer incidence and deaths to 2030:the unexpected burden of thyroid,liver,and pancreas cancers in the United States[J].Cancer Res,2014,74(11):2913-21.doi:10.1158/0008-5472.CAN-14-0155.
[3] Slack F J,Chinnaiyan A M.The role of non-coding RNAs in oncology[J].Cell,2019,179(5):1033-55.doi:10.1016/j.cell.2019.10.017.
[4] Shen X,Zhang Y,Wu X,et al.Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum[J].Cancer Biomark,2017,18(3):257-63.doi:10.3233/CBM-160158.
[5] Xing C,Sun S G,Yue Z Q,et al.Role of lncRNA LUCAT1 in cancer[J].Biomed Pharmacother,2021,134:111158.doi:10.1016/j.biopha.2020.111158.
[6] Sun Y,Jin S D,Zhu Q,et al.Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression[J].Oncotarget,2017,8(17):28297-311.doi:10.18632/oncotarget.16044.
[7] Yoon J H,You B H,Park C H,et al.The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma[J].Cancer Lett,2018,417:47-57.doi:10.1016/j.canlet.2017.12.016.
[8] Zheng A,Song X,Zhang L,et al.Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway[J].J Exp Clin Cancer Res,2019,38(1):305.doi:10.1186/s13046-019-1315-8.
[9] Zhou Q,Hou Z,Zuo S,et al.LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52[J].Cancer Sci,2019,110(4):1194-207.doi:10.1111/cas.13951.
[10] 骆广涛，汤为香，裘正军.低氧条件下Akt抑制剂MK-2206增强胰腺癌细胞对吉西他滨敏感性的作用研究[J].安徽医科大学学报，2020,55(2):166-71.doi:10.19405/j.cnki.issn1000-1492.2020.02.003.[10] Luo G T,Tang W X,Qiu Z J.Mechanism of Akt inhibitor MK-2206 in enhancing the sensitivity of pancreatic cancer cells to gemcitabine under hypoxia[J].Acta Univ Med Anhui,2020,55(2):166-71.doi:10.19405/j.cnki.issn1000-1492.2020.02.003.
[11] Wang X,Guo S,Zhao R,et al.STAT3-Activated long non-coding RNA lung cancer associated transcript 1 drives cell proliferation,migration,and invasion in hepatoblastoma through regulation of the miR-301b/STAT3 axis[J].Hum Gene Ther,2019,30(6):702-13.doi:10.1089/hum.2018.146.
[12] Cao W,Zhang H F,Ding X L,et al.The progression of pancreatic cancer cells is promoted by a long non-coding RNA LUCAT1 by activating AKT phosphorylation[J].Eur Rev Med Pharmacol Sci,2021,25(2):738-48.doi:10.26355/eurrev_202101_24635.
[13] Huan L,Guo T,Wu Y,et al.Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response[J].Mol Cancer,2020,19(1):11.doi:10.1186/s12943-019-1122-z.
[14] Lou Y,Yu Y,Xu X,et al.Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma[J].J Cell Mol Med,2019,23(3):1873-84.doi:10.1111/jcmm.14088.
[15] Xu F,Huang M,Chen Q,et al.LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT/YB1/HIF1α pathway[J].Cancer Res,2021,81(22):5678-91.doi:10.1158/0008-5472.CAN-21-0281.
[16] Huan L,Guo T,Wu Y,et al.Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response[J].Mol Cancer,2020,19(1):11.doi:10.1186/s12943-019-1122-z.
基本信息:
DOI：10.19405/j.cnki.issn1000-1492.2025.02.001
中图分类号:R735.9
引用信息:
[1]叶梦洁,瞿薇薇,骆广涛.长链非编码RNA LUCAT1调控胰腺癌MIA PaCa-2细胞恶性机制研究[J].安徽医科大学学报,2025,60(02):187-194.DOI:10.19405/j.cnki.issn1000-1492.2025.02.001.
基金信息:
国家自然科学基金(编号：82002534); 安徽省转化医学研究院科研基金(编号：2022zhyx-C71)~~